Azelaic acid is a lipid of Fatty Acyls (FA) class. Azelaic acid is associated with abnormalities such as Bacterial Infections and Infection. The involved functions are known as Anabolism, Signal Transduction, Plant Immunity, Signal and Signal Transduction Pathways. Azelaic acid often locates in Body tissue. The associated genes with Azelaic acid are AZI1 gene, FKBPL gene and MLL gene. The related lipids are sebacic acid.
To understand associated biological information of Azelaic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Azelaic acid is suspected in Infection, Bacterial Infections and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Azelaic acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Azelaic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Iraji F et al. | Efficacy of 15% azelaic acid in psoriasis vulgaris: a randomized, controlled clinical trial. | 2010 | J Drugs Dermatol | pmid:20684146 |
Kircik LH | Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study. | 2011 | J Drugs Dermatol | pmid:21637899 |
Wheeland RG and Dhawan S | Evaluation of self-treatment of mild-to-moderate facial acne with a blue light treatment system. | 2011 | J Drugs Dermatol | pmid:21637900 |
Thiboutot DM et al. | A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. | 2009 | J Drugs Dermatol | pmid:19588640 |
Del Rosso JQ et al. | Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea. | 2010 | J Drugs Dermatol | pmid:20645521 |
Conde JF et al. | Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. | 2007 | J Drugs Dermatol | pmid:17679183 |
Thiboutot D | Versatility of azelaic acid 15% gel in treatment of inflammatory acne vulgaris. | 2008 | J Drugs Dermatol | pmid:18246693 |
Nally JB and Berson DS | Topical therapies for rosacea. | 2006 | J Drugs Dermatol | pmid:16468288 |
Fleischer A and Suephy C | The face and mind evaluation study: an examination of the efficacy of rosacea treatment using physician ratings and patients' self-reported quality of life. | 2005 Sep-Oct | J Drugs Dermatol | pmid:16167417 |
Jackson JM et al. | Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosacea. | 2013 | J Drugs Dermatol | pmid:23545911 |
Shalita AR et al. | Inflammatory acne management with a novel prescription dietary supplement. | 2012 | J Drugs Dermatol | pmid:23377512 |
Manosroi A et al. | Characteristics and anti-proliferative activity of azelaic acid and its derivatives entrapped in bilayer vesicles in cancer cell lines. | 2007 | J Drug Target | pmid:17541842 |
Choi YS et al. | A study of the efficacy of cleansers for acne vulgaris. | 2010 | J Dermatolog Treat | pmid:20394494 |
Pazoki-Toroudi H et al. | Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. | 2010 | J Dermatolog Treat | pmid:20394495 |
Asai Y et al. | Canadian Clinical Practice Guidelines for Rosacea. | 2016 | J Cutan Med Surg | pmid:27207355 |
Patwardhan N | Conference Report: ACSICON 2008. | 2009 | J Cutan Aesthet Surg | pmid:20300376 |
Esposito E et al. | Ethosomes and liposomes as topical vehicles for azelaic acid: a preformulation study. | 2004 May-Jun | J Cosmet Sci | pmid:15264053 |
Lee GS | Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report. | 2008 | J Cosmet Laser Ther | pmid:18830869 |
Draelos ZD et al. | An evaluation of a polyhydroxy acid skin care regimen in combination with azelaic acid 15% gel in rosacea patients. | 2006 | J Cosmet Dermatol | pmid:17173568 |
Farshi S | Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma. | 2011 | J Cosmet Dermatol | pmid:22151936 |
Arizaga GG et al. | Chemical modification of zinc hydroxide nitrate and Zn-Al-layered double hydroxide with dicarboxylic acids. | 2008 | J Colloid Interface Sci | pmid:18243238 |
Jones DA | Rosacea, reactive oxygen species, and azelaic Acid. | 2009 | J Clin Aesthet Dermatol | pmid:20967185 |
McFalda WL and Roebuck HL | Rational management of papulopustular rosacea with concomitant facial seborrheic dermatitis: a case report. | 2011 | J Clin Aesthet Dermatol | pmid:21278898 |
Del Rosso JQ | The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. | 2009 | J Clin Aesthet Dermatol | pmid:20729951 |
Davis EC and Callender VD | Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. | 2010 | J Clin Aesthet Dermatol | pmid:20725554 |
Salimon J et al. | Synthesis and physical properties of estolide ester using saturated Fatty Acid and ricinoleic Acid. | 2011 | J Autom Methods Manag Chem | pmid:22007150 |
Maes M et al. | Increased autoimmune responses against auto-epitopes modified by oxidative and nitrosative damage in depression: implications for the pathways to chronic depression and neuroprogression. | 2013 | J Affect Disord | pmid:22898471 |
Verma P and Pathak K | Therapeutic and cosmeceutical potential of ethosomes: An overview. | 2010 | J Adv Pharm Technol Res | pmid:22247858 |
Chudasama A et al. | Investigation of microemulsion system for transdermal delivery of itraconazole. | 2011 | J Adv Pharm Technol Res | pmid:22171289 |
Karimi AA et al. | Improvement of tissue survival of skin flaps by 5α-reductase inhibitors: possible involvement of nitric oxide and inducible nitric oxide synthase. | 2015 | Iran. Biomed. J. | pmid:25864816 |
Breathnach AS et al. | Effect of dicarboxylic acids (C6 and C9) on human choroidal melanoma in cell culture. | 1989 | Invest. Ophthalmol. Vis. Sci. | pmid:2925320 |
Le Lay C et al. | Identification and quantification of antifungal compounds produced by lactic acid bacteria and propionibacteria. | 2016 | Int. J. Food Microbiol. | pmid:27350657 |
Gupta AK and Gover MD | Azelaic acid (15% gel) in the treatment of acne rosacea. | 2007 | Int. J. Dermatol. | pmid:17472690 |
Baliña LM and Graupe K | The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. | 1991 | Int. J. Dermatol. | pmid:1816137 |
Nguyen QH and Bui TP | Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. | 1995 | Int. J. Dermatol. | pmid:7737781 |
RodrÃguez Prieto MA et al. | Treatment of lentigo maligna with azelaic acid. | 1993 | Int. J. Dermatol. | pmid:8505164 |
Vereecken P and Heenen M | Recurrent lentigo maligna melanoma: regression associated with local azelaic acid 20%. | 2002 Jan-Feb | Int. J. Clin. Pract. | pmid:11831841 |
Li N et al. | Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid. | 2010 | Int J Pharm | pmid:20025951 |
Manosroi J et al. | Enhancement of the release of azelaic acid through the synthetic membranes by inclusion complex formation with hydroxypropyl-beta-cyclodextrin. | 2005 | Int J Pharm | pmid:15778061 |
Karavelidis V et al. | Evaluating the effects of crystallinity in new biocompatible polyester nanocarriers on drug release behavior. | 2011 | Int J Nanomedicine | pmid:22162659 |
Smit N et al. | The hunt for natural skin whitening agents. | 2009 | Int J Mol Sci | pmid:20054473 |
Ebanks JP et al. | Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. | 2009 | Int J Mol Sci | pmid:19865532 |
Sarkar R et al. | Newer and upcoming therapies for melasma. | 2012 Jul-Aug | Indian J Dermatol Venereol Leprol | pmid:22772611 |
Iraji F et al. | Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris. | 2007 Mar-Apr | Indian J Dermatol Venereol Leprol | pmid:17456913 |
Khanna N and Rasool S | Facial melanoses: Indian perspective. | 2011 Sep-Oct | Indian J Dermatol Venereol Leprol | pmid:21860153 |
Ghosh S | Chemical leukoderma: what's new on etiopathological and clinical aspects? | 2010 Jul-Sep | Indian J Dermatol | pmid:21063518 |
Safoury OS et al. | A study comparing chemical peeling using modified Jessner's solution and 15% trichloroacetic Acid versus 15% trichloroacetic acid in the treatment of melasma. | 2009 | Indian J Dermatol | pmid:20049268 |
Rathi SK | Acne vulgaris treatment : the current scenario. | 2011 | Indian J Dermatol | pmid:21572783 |
Bandyopadhyay D | Topical treatment of melasma. | 2009 | Indian J Dermatol | pmid:20101327 |
Panyosak A et al. | Safety assessment of azelaic acid and its derivatives entrapped in nanovesicles. | 2009 | Hum Exp Toxicol | pmid:19755450 |